Fig. 3From: Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysisComparison of local recurrence-free survival (a), regional recurrence-free survival (b), distant metastasis recurrence-free survival (c), and recurrence-free survival (d) of patients in lobectomy or SBRT group after propensity score matching. SBRT = stereotactic body radiation therapyBack to article page